Exploring Challenges to COVID-19 Vaccination in the Darfur Region of Sudan

Abstract

The current COVID-19 pandemic has affected the ability of health systems to provide essential services globally. The Darfur region, located in the western part of Sudan, has been largely devastated by the war that began in 2003 and has been drawing considerable attention from the international community. The war, which erupted as a result of environmental, political, and economic factors, has led to tragic outcomes. Collapsing health-care infrastructures, health workforce shortages, lack of storage facilities for medicines and medical products, and inadequate access to health services are some of the effects of the war. After Sudan received the AstraZeneca COVID-19 vaccine through the COVID-19 Vaccines Global Access facility, significant challenges have been implicated in the delivery, storage, and use of the vaccine in the Darfur region. Lack of vaccine storage and transportation facilities, vaccination hesitancy, inequity in the distribution to health facilities, and shortage of health-care professionals resulting from insecurity and instability have added an extra layer of burden on local authorities and their ability to manage COVID-19 vaccinations in the region adequately. Addressing the impact of COVID-19 requires an effectively managed vaccination program. In the face of current challenges in Darfur, ensuring a fully vaccinated population might remain far-fetched and improbable if meaningful efforts are not put in place by all stakeholders and actors to address some of the challenges identified.

Acceptance of COVID‐19 booster vaccination based on the protection motivation theory: A cross‐sectional study in China

“…Among them, VH and vaccine inequity are two major issues in the mass vaccination strategy for COVID‐19 control 46 . To some extent, VH and vaccine inequity are correlated with the local level of economy, health service, and production capacity 47 . An in‐depth understanding of people's attitude to booster shots would not only improve vaccination coverage in different regions but also increase incentives to expand production scale and develop a novel generation of vaccines for vaccine manufacturers, which will be helpful to reduce the social inequities and rehabilitate the social economy.…”

COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study

“…In addition, our studies showed a higher actual vaccine coverage with at least one dose in Chinese DM patients (87.7%) compared with the study in India (21.4%) and Sudan (31.0%). The potential reason might be associated with the later investigation time in this study compared with others and the shortage of vaccination supply in India ( 28 ) and Sudan ( 29 ).…”

Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review

“…Challenges faced included vaccine scepticism due to distrust of the fast-paced vaccine development process [ 28 ], historical distrust in the formal healthcare system, fear of side effects, and misinformation [ 32 , 37 ]. A vaccination program in South Africa adopted the risk versus benefit approach in its communication strategy—acknowledging the rare chances of adverse vaccine reactions which are manageable but stressed on the higher probability of developing severe COVID-19 disease that can be life threatening and the key role of the vaccine in preventing it [ 39 ].…”

“…There were logistical constraints in vaccine storage and transportation due to inadequate infrastructure, an inequitable spread of health facilities that excludes certain sub-populations from accessing care, and the short shelf life of vaccines [ 34 , 37 ]. The lack of timely data on COVID-19 vaccine safety and efficacy for pregnant women posed challenges to uptake in this population [ 29 ].…”